NZ183626A - 2-(2-(2-aminopyrimid-4-yl)-ehten-1-yl)-quinoxaline-1,4-dioxides - Google Patents

2-(2-(2-aminopyrimid-4-yl)-ehten-1-yl)-quinoxaline-1,4-dioxides

Info

Publication number
NZ183626A
NZ183626A NZ183626A NZ18362677A NZ183626A NZ 183626 A NZ183626 A NZ 183626A NZ 183626 A NZ183626 A NZ 183626A NZ 18362677 A NZ18362677 A NZ 18362677A NZ 183626 A NZ183626 A NZ 183626A
Authority
NZ
New Zealand
Prior art keywords
ehten
aminopyrimid
dioxides
quinoxaline
Prior art date
Application number
NZ183626A
Other languages
English (en)
Inventor
A Garzia
A Bottazzi
W Ferrari
Original Assignee
Istituto Chemioterapico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/771,118 external-priority patent/US4076815A/en
Application filed by Istituto Chemioterapico filed Critical Istituto Chemioterapico
Publication of NZ183626A publication Critical patent/NZ183626A/xx

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NZ183626A 1976-03-31 1977-03-16 2-(2-(2-aminopyrimid-4-yl)-ehten-1-yl)-quinoxaline-1,4-dioxides NZ183626A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67212376A 1976-03-31 1976-03-31
US05/771,118 US4076815A (en) 1976-03-31 1977-02-23 Quinoxaline compound and composition, process for preparing compound, and method of combatting cholera therewith

Publications (1)

Publication Number Publication Date
NZ183626A true NZ183626A (en) 1978-11-13

Family

ID=27100689

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ183626A NZ183626A (en) 1976-03-31 1977-03-16 2-(2-(2-aminopyrimid-4-yl)-ehten-1-yl)-quinoxaline-1,4-dioxides

Country Status (14)

Country Link
JP (1) JPS52139087A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR212615A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE852913A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1069899A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2714157A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK143701C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES457359A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1536393A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE45275B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN144232B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX4659E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7703465A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ183626A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH12676A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Also Published As

Publication number Publication date
DK143701B (da) 1981-09-28
IE45275B1 (en) 1982-07-28
MX4659E (es) 1982-07-19
IN144232B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-04-08
IE45275L (en) 1977-09-30
CA1069899A (en) 1980-01-15
JPS5437154B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-11-13
NL7703465A (nl) 1977-10-04
PH12676A (en) 1979-07-11
DE2714157A1 (de) 1977-10-27
JPS52139087A (en) 1977-11-19
BE852913A (fr) 1977-09-26
ES457359A1 (es) 1978-06-16
GB1536393A (en) 1978-12-20
DK143701C (da) 1982-04-05
DK140377A (da) 1977-10-01
AR212615A1 (es) 1978-08-15

Similar Documents

Publication Publication Date Title
KE3221A (en) 2-piperazinyl-6,7-dimethoxyquinazolines
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
NZ183143A (en) 2-aminoakyl-1,2-benzisothiazol 3-anes
NZ184050A (en) 2-substituted amino-4-amono-6,7-demethoxy-quinzaolines
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
GB1556569A (en) 1,5-disubstituted - 2 - pyrrolidones
IL52424A0 (en) 2,6-methano-2h-1-benzoxocins
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
AU2468877A (en) 1,4 -dicyanobytene
ZA777163B (en) 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
GB1537635A (en) 15,16-dihydroxyprostaglandins
IL53527A (en) N1-chloro-3,5-dinitrosulfanilamides
NZ184082A (en) 1-benzothiazol-2yl-1,3-imidazolidin-2-ones
GB1554049A (en) 2-decarboxy-2-hydroxymethyl-13,14-didehydroprostaglandins
GB1547729A (en) 1-phenyl-4-acetoxy-1,2-dihydroquinolin-2-ones
GB1545982A (en) 2-oxo-2,3-dihydroindoles
NZ183626A (en) 2-(2-(2-aminopyrimid-4-yl)-ehten-1-yl)-quinoxaline-1,4-dioxides
GB1546347A (en) 5,11-diazatetracyclo-(6.2.2.02,7 04,9)-dodecanes
GB1541820A (en) 1,4-oxathianes
IE44680L (en) Trifluoromethylthio compounds.
GB1554045A (en) 13,14-didehydroprostaglandins
EG12897A (en) N,n,methylebebis-co,o-diaryl-n-phosphonomethylglycinonitrilles
CS186513B1 (en) Jurcik,lubos,cs
CS186521B1 (en) Cizmar,ludek,cs
CS187753B1 (en) Bravenec,jindrich,cs